Log In
Print this Print this

Qnasl, beclomethasone dipropionate nasal aerosol

Also known as: Qnaze

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionNasal aerosol non-aqueous formulation of beclomethasone dipropionate in a hydrofluoroalkane (HFA) metered-dose spray
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRhinitis
Indication DetailsTreat pediatric allergic rhinitis; Treat perennial allergic rhinitis (PAR); Treat seasonal allergic rhinitis (SAR); Treat seasonal and perennial allergic rhinitis (SAR and PAR); Treat seasonal and perennial allergic rhinitis in children ages 4-11 years
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today